Table: Nippon Shinyaku -2019/20 group results
May 13 (Reuters)-
Nippon Shinyaku Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 116.64 114.72 126.00 59.50
(+1.7 pct) (+13.1 pct) (+8.0 pct) (+3.7 pct)
Operating 21.67 20.64 25.00 10.00
(+5.0 pct) (+20.9 pct) (+15.4 pct) (-9.3 pct)
Recurring 22.44 21.54 25.50 10.20
(+4.2 pct) (+23.4 pct) (+13.6 pct) (-9.5 pct)
Net
Net 16.87 16.30 19.00 7.20
(+3.5 pct) (+25.9 pct) (+12.6 pct) (-13.2 pct)
EPS 250.42 yen 242.04 yen 282.09 yen 106.90 yen
Ann Div 86.00 yen 70.00 yen 99.00 yen
-Q2 Div 43.00 yen 29.00 yen 49.00 yen
-Q4 Div 43.00 yen 41.00 yen 50.00 yen
NOTE - Nippon Shinyaku Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4516.T
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)